KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Diversified Healthcare Trust (DHC) Change in Accured Expenses (2016 - 2025)

Diversified Healthcare Trust (DHC) has disclosed Change in Accured Expenses for 17 consecutive years, with $43.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Accured Expenses rose 791.73% year-over-year to $43.3 million, compared with a TTM value of $32.6 million through Dec 2025, up 600.52%, and an annual FY2025 reading of $32.6 million, up 600.52% over the prior year.
  • Change in Accured Expenses was $43.3 million for Q4 2025 at Diversified Healthcare Trust, up from -$11.0 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $43.3 million in Q4 2025 and bottomed at -$25.5 million in Q3 2021.
  • Average Change in Accured Expenses over 5 years is $1.3 million, with a median of -$581000.0 recorded in 2024.
  • Peak annual rise in Change in Accured Expenses hit 791.73% in 2025, while the deepest fall reached 1623.67% in 2025.
  • Year by year, Change in Accured Expenses stood at $16.8 million in 2021, then tumbled by 137.08% to -$6.2 million in 2022, then crashed by 47.4% to -$9.2 million in 2023, then skyrocketed by 31.91% to -$6.3 million in 2024, then surged by 791.73% to $43.3 million in 2025.
  • Business Quant data shows Change in Accured Expenses for DHC at $43.3 million in Q4 2025, -$11.0 million in Q3 2025, and $2.0 million in Q2 2025.